Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
A Single-center Exploratory Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of a BCMA-targeted Universal LCAR-BCX Cells in Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04601935. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT06183489. IPD Sharing: Not stated. Countries: 6. Publications: 0.
A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
ClinicalTrials.gov study NCT01723020. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Viral Immunotherapy in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03015922. IPD Sharing: NO. Countries: 1. Publications: 0.
Fixed Duration vs Continuous Daratumumab in Transplant Ineligible Older Adults With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT06182774. IPD Sharing: YES. Countries: 1. Publications: 0.
Multiple Myeloma Patient Registry
ClinicalTrials.gov study NCT03180853. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GMMG Multiple Myeloma Registry
ClinicalTrials.gov study NCT07111884. IPD Sharing: YES. Countries: 1. Publications: 0.
Paclitaxel,Cyclophosphamide and Dexamethasone for Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02985333. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00457782. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease
ClinicalTrials.gov study NCT06627751. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT06140966. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase II Study of Daratumumab Pre-Mobilization and Post-ASCT in Multiple Myeloma
ClinicalTrials.gov study NCT04230031. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00478075. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prospective Cohort of Single-dose Radiotherapy for Painful Bone Lesions in Multiple Myeloma
ClinicalTrials.gov study NCT05996367. IPD Sharing: NO. Countries: 1. Publications: 0.
Belantamab Mafodotin, Lenalidomide, and Daratumumab for the Treatment of Relapsed, Refractory, or Previously Untreated Multiple Myeloma
ClinicalTrials.gov study NCT04892264. IPD Sharing: Not stated. Countries: 1. Publications: 0.
B Cell Maturation Antigen（BMCA）-Targeted CAR-T for Refractory/Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT03931421. IPD Sharing: YES. Countries: 1. Publications: 0.
Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma
ClinicalTrials.gov study NCT01609816. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
ClinicalTrials.gov study NCT06630104. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04883242. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase II Trial Comparing the Quality of Life, Tolerability and Toxicity of PEG Intron With INTRON® A in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00323505. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.